The Institute of Medical Sciences (IMS) and SUM Hospital has become the first hospital in Odisha to establish an in-house genomics facility, enabling advanced molecular diagnostics and precision ...

Immunology researchers are working to understand complex adaptive immune responses, but meaningful signals are often rare, transient, or difficult to capture across large, sample-limited studies.

Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...

Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the dual listing of its common stock on NYSE Texas ...

Multiomics data integration with machine learning has become the standard approach for combining genomic, transcriptomic, proteomic, and metabolomic measurements collected from the same biological ...

Study finds obesity drives breast cancer invasion through a unique molecular pathway, separate from known risk factors.

Is CAI a good stock to buy? We came across a bullish thesis on Caris Life Sciences, Inc. on InfoArb Sheets’s Substack. In ...

Dissecting protective versus detrimental immune responses uncovers biomarkers and mechanisms that can inform the rational design and evaluation of live attenuated vaccines against African swine fever ...

High-resolution spatial transcriptomics and imaging-based technologies are now generating large-scale, multi-dimensional datasets that are beginning to reshape how we understand tissue organisation, ...